A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia

Clinical trial NCT00400673 · COMPLETED

Trial details

NCT number: NCT00400673
Sponsor: Northern Italy Leukemia Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2000-05-01
Primary completion: 2007-10-01
Enrollment: 581

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.